COVID-19 drug lead treatments identified
An international team of researchers has tested more than 10,000 compounds to identify six drug candidates that may help treat COVID-19.
“Currently there are no targeted therapeutics or effective treatment options for COVID-19,” Professor Guddat said.
“In order to rapidly discover lead compounds for clinical use, we initiated a program of high-throughput drug screening, both in laboratories and also using the latest computer software to predict how different drugs bind to the virus.
Professor Guddat said the project targeted the main COVID-19 virus enzyme, known as the main protease or Mpro, which plays a pivotal role in mediating viral replication.
“This makes it an attractive drug target for this virus, and as people don’t naturally have this enzyme, compounds that target it are likely to have low toxicity.
“We add the drugs directly to the enzyme or to cell cultures growing the virus and assess how much of each compound is required to stop the enzyme from working or to kill the virus.
“If the amount is small, then we have a promising compound for further studies.”
After assaying thousands of drugs, researchers found of the six that appear to be effective in inhibiting the enzyme, one is of particular interest.
“We’re particularly looking at several leads that have been subjected to clinical trials including for the prevention and treatment of various disorders such as cardiovascular diseases, arthritis, stroke, atherosclerosis and cancer,” Professor Guddat said.
“Compounds that are already along the pipeline to drug discovery are preferred, as they can be further tested as antivirals at an accelerated rate compared to new drug leads that would have to go through this process from scratch.”
After the enzyme’s structure was made public, the team received more than 300 requests for more information, even before the paper was published.
“To provide an analogy, we’ve provided scientists with a fishing pole, the line and the exact bait, and have in only one month caught some fish,” Professor Guddat said.
“Now it’s up to us and the other fisherman – our fellow scientists globally – to take full advantage of this breakthrough.”
“With continued and up-scaled efforts we are optimistic that new candidates can enter the COVID-19 drug discovery pipeline in the near future.”
The international collaboration was led by researchers at ShanghaiTech University.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Arizona state Rep. Lorenzo Sierra hospitalized with COVID-19; lawmaker in ICU, intubatedon October 7, 2020 at 2:35 am
A spokesperson for House Democrats said Sierra was hospitalized Sunday evening and taken to The Johns Hopkins Hospital in Baltimore ...
- Trump's COVID-19 Treatment Hangs Over Vice Presidential Debateon October 7, 2020 at 2:05 am
Vice President Mike Pence and Democratic vice presidential nominee Kamala Harris have their only debate Wednesday in Salt Lake City. Amid the White House COVID-19 outbreak, the stage has changed.
- Donald Trump's COVID-19 treatment is similar to the average American hospitalized with coronavirus. Only faster.on October 7, 2020 at 12:22 am
President Trump received mostly the same treatment as anyone would get for COVID-19, except for one experimental drug and the speed of his care.
- Dexamethasone: Here Are The Side Effects Of The Covid-19 Coronavirus Treatment That Trump Receivedon October 6, 2020 at 10:42 pm
Dexamethasone has shown promise in decreasing the risk of death for patients with more severe Covid-19 coronavirus infections. But getting dexamethasone isn’t like eating baked ziti. Corticosteroids ...
- Yale doctor on Trump's COVID-19 treatment and health conditionon October 6, 2020 at 8:53 pm
President Trump is back at the White House but his doctors are warning he is "not out of the woods" yet. Dr. James Hamblin is a lecturer at the Yale School of Public Health, staff writer at The ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Australia expects COVID-19 vaccination is still a year awayon October 7, 2020 at 2:57 am
Australia considered a rollout of a coronavirus vaccine no sooner than mid-2021 a best-case scenario in its pandemic planning that would save the economy tens of billions of dollars, the treasurer ...
- Czech COVID-19 Cases Rising at Fastest Rate in Europeon October 7, 2020 at 2:46 am
The Czech Republic reported a record 4,457 new coronavirus cases in a single day, Health Ministry data showed on Wednesday, as a spike in infections over the past month is now rising at Europe's ...
- From Trump on down, people of means have shaped our COVID-19 experience. That must change.on October 7, 2020 at 2:42 am
White House butlers, maids, plumbers, florists, doormen and cooks were not in that Rose Garden photo and their positive COVID tests don't make headlines.
- Pence, Harris to debate in sole VP matchup of 2020 amid heightened COVID-19 concernson October 7, 2020 at 2:41 am
Vice President Mike Pence and Sen. Kamala Harris of California will debate in Salt Lake City on Tuesday in the sole matchup between the 2020 vice presidential candidates.
- Hospitals Failing To Meet New COVID-19 Data Reporting Mandate To Get Warning Letterson October 7, 2020 at 2:30 am
New enforcement guidelines are now in place, pushing hospitals to comply with rigorous reporting requirements, or risk losing a crucial funding stream from the federal government.